Peter LANGECKER

Person

Monte Sereno, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Camptothecin derivatives and uses thereof
- Patent number 10,407,437
- Issue date Sep 10, 2019
- Los Gatos Pharmaceuticals, Inc.
- Peter Langecker
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Composite nanoparticles and uses thereof
- Patent number 10,064,855
- Issue date Sep 4, 2018
- Los Gatos Pharmaceuticals, Inc.
- Peter Langecker
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
SUSTAINED RELEASE DRUG DELIVERY SYSTEMS AND RELATED METHODS
- Publication number 20220273633
- Publication date Sep 1, 2022
- DURECT CORPORATION
- ADRIAN NEIL VERITY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Composite Nanoparticles And Uses Thereof
- Publication number 20180369232
- Publication date Dec 27, 2018
- Los Gatos Pharmaceuticals, Inc.
- Peter Langecker
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITE NANOPARTICLES AND USES THEREOF
- Publication number 20170258785
- Publication date Sep 14, 2017
- Los Gatos Pharmaceuticals, Inc.
- Peter Langecker
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CAMPTOTHECIN DERIVATIVES AND USES THEREOF
- Publication number 20170260194
- Publication date Sep 14, 2017
- Los Gatos Pharmaceuticals, Inc.
- Peter Langecker
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Treatment of Hyperproliferative Disorders Using Cardiac Glycosides
- Publication number 20160331771
- Publication date Nov 17, 2016
- EPICENTRX, INC.
- Bryan T. Oronsky
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Treatment of Hyperproliferative Disorders Using Cardiac Glycosides
- Publication number 20110250297
- Publication date Oct 13, 2011
- Bryan T. Oronsky
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION THERAPY USING PHOSPHODIESTERASE INHIBITORS
- Publication number 20100104624
- Publication date Apr 29, 2010
- Peter LANGECKER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Method for treating diseases with omega interferon
- Publication number 20070248572
- Publication date Oct 25, 2007
- INTARICA THERAPEUTICS, INC.
- S. Mark Moran
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Combination therapy for the treatment of estrogen-sensitive drugs
- Publication number 20050232862
- Publication date Oct 20, 2005
- Intarcia Therapeutics, Inc.
- S. Mark Moran
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Combination therapy for the treatment of estrogen-sensitive disease
- Publication number 20050228053
- Publication date Oct 13, 2005
- Intarcia Therapeutics, Inc.
- Stanford Mark Moran
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Combination therapy for the treatment of estrogen-sensitive disease
- Publication number 20050176691
- Publication date Aug 11, 2005
- Stanford Mark Moran
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Combination therapy for the treatment of estrogen-sensitive disease
- Publication number 20050130945
- Publication date Jun 16, 2005
- Stanford Mark Moran
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
3-heteroarylidenyl-2-indolinone compounds for modulating protein ki...
- Publication number 20030191162
- Publication date Oct 9, 2003
- Sugen. Inc.
- Peter J. Langecker
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Method for treating diseases with omega interferon
- Publication number 20030143197
- Publication date Jul 31, 2003
- S. Mark Moran
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
3-HETEROARYLIDENYL-2-INDOLINONE COMPOUNDS FOR MODULATING PROTEIN KI...
- Publication number 20030073837
- Publication date Apr 17, 2003
- PETER J. LANGECKER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Combination therapy for the treatment of estrogen-sensitive disease
- Publication number 20020119502
- Publication date Aug 29, 2002
- Mark Stanford Moran
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Peter LANGECKER

Person

Patents Grantslast 30 patents

Camptothecin derivatives and uses thereof

Composite nanoparticles and uses thereof

Patents Applicationslast 30 patents

SUSTAINED RELEASE DRUG DELIVERY SYSTEMS AND RELATED METHODS

Composite Nanoparticles And Uses Thereof

COMPOSITE NANOPARTICLES AND USES THEREOF

CAMPTOTHECIN DERIVATIVES AND USES THEREOF

Treatment of Hyperproliferative Disorders Using Cardiac Glycosides

Treatment of Hyperproliferative Disorders Using Cardiac Glycosides

COMBINATION THERAPY USING PHOSPHODIESTERASE INHIBITORS

Method for treating diseases with omega interferon

Combination therapy for the treatment of estrogen-sensitive drugs

Combination therapy for the treatment of estrogen-sensitive disease

Combination therapy for the treatment of estrogen-sensitive disease

Combination therapy for the treatment of estrogen-sensitive disease

3-heteroarylidenyl-2-indolinone compounds for modulating protein ki...

Method for treating diseases with omega interferon

3-HETEROARYLIDENYL-2-INDOLINONE COMPOUNDS FOR MODULATING PROTEIN KI...

Combination therapy for the treatment of estrogen-sensitive disease